YSEI SHH-SSGD Multi-Chamber Integrated Drug Stability Testing System

Overview

The YSEI SHH-SSGD Multi-Chamber Integrated Drug Stability Testing System is an engineered solution for pharmaceutical stability studies in compliance with globally harmonized regulatory frameworks—including ICH Q1A(R3), Q1B, Q1C, Q1D, and Q5C—as well as United States Pharmacopeia (USP) and the Chinese Pharmacopoeia (2020 Edition, General Chapter 9001). Designed specifically for long-term, accelerated, intermediate, and stress condition testing (e.g., light exposure, low-humidity desiccation), this system implements precise environmental control across multiple independent chambers within a single footprint. Each chamber operates under fully autonomous temperature and relative humidity setpoints, enabling concurrent execution of distinct ICH protocols—such as 25°C/60% RH (long-term), 40°C/75% RH (accelerated), and 40°C/20% RH (low-RH stress)—without cross-chamber interference. The system employs dual PID-controlled refrigeration circuits, steam-based humidification with deionized water feed, and high-efficiency axial airflow distribution to ensure spatial uniformity (±0.5°C temperature, ±3% RH) throughout the working volume. Its architecture supports continuous 24/7 operation over extended durations (>12 months), fulfilling the rigorous reproducibility and traceability requirements of GLP- and GMP-regulated environments.

Key Features

• Fully independent chamber control: Each chamber maintains discrete temperature (0–60°C) and humidity (10–95% RH) profiles, eliminating protocol conflicts during parallel studies.
• Low-humidity capability: Engineered to sustain 20% RH at 40°C—critical for evaluating moisture-sensitive formulations including large-volume parenterals and lyophilized biologics.
• Regulatory-grade data integrity: Thermal printer provides time-stamped, tamper-evident paper records; digital logs include full audit trail, user authentication, and electronic signature support compliant with FDA 21 CFR Part 11.
• Energy-optimized thermal management: Variable-speed compressors, insulated double-wall construction, and adaptive defrost cycles reduce average power draw to ≤2.8 kW per chamber under standard test conditions.
• Acoustic optimization: Sound pressure level <52 dB(A) at 1 m distance ensures compatibility with shared laboratory spaces and cleanroom-adjacent installations.
• Multi-layer safety architecture: Includes chamber-specific overtemperature cutoff, humidifier dry-run detection, refrigeration compressor thermal overload protection, and redundant sensor validation.

Sample Compatibility & Compliance

The SHH-SSGD accommodates a broad range of pharmaceutical dosage forms—including tablets, capsules, injectables, ointments, inhalers, and sterile solutions—within standardized stability storage configurations (e.g., ICH-aligned tray loading, light-exposure racks with UV-filtered lamps). All chambers are validated per ISO 14644-1 Class 8 (ISO Class 100,000) air cleanliness requirements when operated in controlled environments. System qualification documentation includes full IQ/OQ protocols aligned with ASTM E2500-13 and Annex 15 of the EU GMP Guidelines. Environmental monitoring sensors are NIST-traceable and calibrated annually per ISO/IEC 17025-accredited procedures. The system supports full lifecycle traceability from installation through routine operational checks and periodic performance verification—meeting requirements for FDA pre-approval inspections and MHRA audit readiness.

Software & Data Management

Data acquisition and reporting are managed via embedded firmware with local touchscreen interface and remote web-based access (HTTPS-secured). Real-time parameters—including chamber temperature, RH, setpoint deviation, alarm status, and compressor duty cycle—are logged at user-defined intervals (1–60 minutes). Historical datasets export directly to CSV or PDF formats via USB 2.0 port. The built-in thermal printer generates hard-copy records with configurable print frequency (e.g., hourly, daily, or event-triggered), each bearing unique batch ID, operator ID, timestamp, and chamber identifier. Audit trail functionality captures all configuration changes, user logins, and alarm acknowledgments with immutable timestamps—fully satisfying 21 CFR Part 11 Subpart B requirements for electronic records and signatures. Optional integration with LIMS or ELN platforms is supported via Modbus TCP or RESTful API.

Applications

• ICH-compliant stability protocol execution: Long-term (25°C/60% RH), accelerated (40°C/75% RH), intermediate (30°C/65% RH), and stress testing (40°C/20% RH, photostability per ICH Q1B).
• Bracketing and matrixing study designs for multi-product or multi-batch evaluations.
• Forced degradation studies supporting analytical method development and specification setting.
• Stability-indicating assay validation under defined environmental stressors.
• Teaching and training applications in academic pharmacology and pharmaceutical sciences programs.
• Post-approval change management (PACM) studies for packaging or formulation modifications.

FAQ

Does the SHH-SSGD support FDA 21 CFR Part 11 compliance?
Yes—the system includes electronic audit trails, role-based user authentication, secure electronic signatures, and immutable record retention for all critical operations.
Can individual chambers be validated separately?
Yes—each chamber is thermally and hygroscopically isolated, allowing independent IQ/OQ/PQ execution per chamber without affecting others.
What humidity range is achievable at 40°C?
The system achieves 20% RH minimum at 40°C, verified per ICH Q1A(R3) Annex 2 for low-humidity stress testing.
Is remote monitoring supported?
Yes—web-based interface enables real-time parameter viewing, alarm notification, and historical data retrieval from any authorized network-connected device.
What validation documentation is provided?
Standard delivery includes IQ/OQ protocols, calibration certificates for all sensors, and a validation summary report; PQ support and on-site execution services are available upon request.